Results for astrazeneca tagrisso

Add to feed Create your own feed

Latest

AstraZeneca gets FDA nod for Tagrisso in certain lung cancers

$AZN AstraZeneca says Tagrisso granted priority review in US via @proactive_UK  #AZN 

AstraZeneca Plc - Tagrisso Adjuvant Lung Cancer US Priority Review Tagrisso Granted Priority Review In US For Adjuvant Treatment Of Patients With Early-Stage EGFR-Mutated Lung Cancer

AstraZeneca’s Tagrisso Continues to Make Strides in Phase III Lung Cancer Trial

$AZN (-2.2% pre) AstraZeneca Tagrisso reduces disease recurrence in brain or death by 82% in lung cancer - SA

AstraZeneca Tagrisso reduces disease recurrence in brain or death by 82% in lung cancer via SeekingAlpha #news  #SA 

AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain

tweet picture

AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain

tweet picture

#ESMO20 : AstraZeneca burnishes Tagrisso's adjuvant NSCLC profile with 'unprecedented' reduction in brain mets. Can they win over skeptics?

Loading
Loading

Most relevant

AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain

tweet picture

AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain

tweet picture

$AZN | AstraZeneca Q2 Earnings: -Revenue: $6.28B (est $6.28B) -Core EPS: 96C (est 93C) -Farxiga Rev: $443M (est $436.6M) -Tagrisso Rev: $1.03B (est $1.02B) -Interim Div/Share: 90C -Retains FY Guidance

AstraZeneca’s blockbuster drug Tagrisso cut the risk of lung cancer death or relapse by four-fifths over three years, according to a study

UPDATED: AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy

AstraZeneca's Tagrisso helps lung cancer patients live longer: study

tweet picture

Loading
Loading